#efta01390959
LightNews LightNews
epsteinweb.bsky.social
Parts 1-2/2 — EFTA01390959.jpg
#epsteinweb #efta01390959
https://epsteinweb.org
EFTA01390959 | EFTA01390959 GLOUS113 Ch11 Mig SOF IV — Project Klein Exclusive deal Expected Glosing Date: El Fund Secondary June 2018 i Secondary Seller type: Key investment data ❑ Single Asset Deal Alternative funds Transaction summary Number of companies 4 Invested Capital at dose E60-100m (US$80-120m) Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Use of leverage No Business services / Healthcare services Average age at purchase 9 years Description Investment rationale / Glendower Team angle - Motivated quality GP aiming to recapitalize and extend their 2007 midmarket pan-European fund while providing liquidity to LPs Glendower Team angle - Ability to quickly deliver a bespoke solution leveraging Glendower's track record in complex transactions - Key value driver is largest independent UK premium distributor in its segment, well positioned to benefit from market tailwinds - Second largest asset is a network of medical and cosmetics UK clinics with a private and affluent customer base - The portfolio also includes an Italian digital marketing company and a management consulting company with blue chip customers - Glendower Capital retains discretion on use of follow-on capital - Ability to perform extensive diligence, including onsite visits, full access to companies' management and industry specialists - Long 15-year relationship with the GP founder Investment rationale - Four well-invested companies positioned to capture growth opportunities arising from ongoing changes in industry landscape - Key value driver led by industry veteran with a solid track record - Value-add potential from recently implemented cost efficiency initiatives - Opportunity to invest in identified follow-ons at closing, and to contribute additional capita! to exploit market dislocations yr disckm.sSon perposesr4y. The investment pjeserged above . s. rml clostei. indthare is no scuatantee that inyestineol cm-ipleaeo; forre part ot i Leire irivsted ponfcCio that be avaliatge sv. aftec fulteei due diligence. prove sugets» for SOF This. Blide hauld be releet and [evle-wc-d in conjunLtion with the -Important Information and "Important Performance Information' and • Notes to Investment Performance sections. Glendower Capital CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL STR1CTLY CONFIDENTIAL DB-SDNY-0095644 SDNY_GM_00241828 EFTA01390959
February 19, 2026 at 7:43 AM